2003P Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
| Autor: | Sternschuss, M., Whiting, K., Teo, M.Y., Bajorin, D., Kotecha, R., Laccetti, A.L., Xiao, H., Feld, E., McHugh, D.J., Keegan, N., Apollo, A., Owens, C., Funt, S.A., Shah, N.J., Iyer, G., Aggen, D.H., Ostrovnaya, I., Rosenberg, J.E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1157-S1158 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|